Las Vegas, NV -- (SBWIRE) -- 01/07/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: GreenGro Technologies, Inc.(OTCMKTS:GRNH), PACIFIC RUBIALES EGY(OTCMKTS:PEGFF), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Bayer AG (ADR)(OTCMKTS:BAYRY)
GreenGro Technologies, Inc.(OTCMKTS:GRNH) increased 39.42% at the price of $0.145recently on a traded volume of 23.49million shares, in comparison to 1.65 million shares of average trading volume. So far this year, the stock is up over 229.55%.
The company has a total market capitalization of $20.88 million and its total outstanding shares are 143.97million. GreenGro Technologies Inc., formerly Authoriszor Inc., provides management services for the planning, construction, staffing and operation of medical marijuana dispensaries, and nurseries on behalf of non-profit patient co-operatives.
For How Long GRNH will Fight for Profitability? Read This Trend Analysis report
PACIFIC RUBIALES EGY(OTCMKTS:PEGFF) plunged -1.02% at the trading price of $17.53 on a traded volume of 67,004.00 shares till now, whereas its average trading volume is 47,327.00 shares. In the last three months, the stock is down -11.73%. The Intra-day range for the stock is $16.78 and $25.25. Pacific Rubiales Energy Corp. engages in the exploration, development, and production of oil and natural gas in Colombia, Peru, Guatemala, Brazil, Papua New Guinea, and Guyana. The company holds interests in the Rubiales, Piriri, and Quifa heavy oil fields in the Llanos Basin, Colombia; and the La Creciente natural gas field in the northwestern Colombia. I
Has PEGFF Found The Bottom And Ready To Gain Momentum? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) dropped down -1.54% at the $2.55recently. So far in three months, the stock is up 292.42%. The 52-week range for the stock is $0.55 and $3.00. Its introductory price for the day was $2.63, with the overall traded volume of 1.11 million shares. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
Why Should Investors Buy PVCT After the Recent Fall? Just Go Here and Find Out
Bayer AG (ADR)(OTCMKTS:BAYRY), after opening its shares at the price of $137.33, jumped up 0.19% , its recent trading price was $137.29 for the day. The stock moved on a traded volume of 19,631.00 shares, in comparison to 49,397.00 shares of average trading volume.
The 52-week range for the stock is $91.58 and $137.54. Its introductory price for the day was $137.33. Bayer AG is a German management holding company with core competencies in the field of health care, nutrition and high-tech materials. It's business operations are organized into three subgroups.
Why Should Investors Buy BAYRY After The Recent Gain? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)